SCHEMBL25259971

SCHEMBL25259971

N#C[C@@]1(c2ccc3c(Cl)ncnn23)O[C@H](COCc2ccccc2)[C@@H](OCc2ccccc2)[C@H]1OCc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 2/20 0.36
▸ PDE2A O00408 1/20 0.34
▸ HTR1A P08908 1/20 0.33
▸ TMPRSS2 O15393 1/20 0.33
▸ EGLN2 Q96KS0 1/20 0.33
▸ PTPN1 P18031 6/20 0.32
▸ CDC25B P30305 6/20 0.32
▸ ACHE P22303 1/20 0.31
▸ PTPN2 P17706 2/20 0.31
▸ PTPN6 P29350 2/20 0.31
▸ PTPN11 Q06124 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20553048 0.90 PDE2A (0.35) BCHEPDE2AHTR1ATMPRSS2PTPN1
SCHEMBL20477154 0.90 PDE2A (0.35) BCHEPDE2AHTR1ATMPRSS2PTPN1
SCHEMBL28408184 0.90 HTR1A (0.33) BCHEPDE2AHTR1ATMPRSS2EGLN2
SCHEMBL29727834 0.90 PDE2A (0.35) BCHEPDE2AHTR1ATMPRSS2PTPN1
SCHEMBL17712276 0.90 PDE2A (0.35) BCHEPDE2AHTR1ATMPRSS2PTPN1
SCHEMBL27086511 0.90 PDE2A (0.35) BCHEPDE2AHTR1ATMPRSS2PTPN1
SCHEMBL12243178 0.90 PDE2A (0.35) BCHEPDE2AHTR1ATMPRSS2PTPN1
SCHEMBL28404433 0.87 PTPN1 (0.33) BCHEPDE2AHTR1ATMPRSS2PTPN1
SCHEMBL15084421 0.87 TMPRSS2 (0.39) BCHEHTR1ATMPRSS2PTPN1CDC25B
SCHEMBL28405132 0.86 BCHE (0.38) BCHEPDE2AHTR1APTPN1CDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023102472-A1 ANTIVIRAL PRODRUGS AND FORMULATIONS THEREOF THE SCRIPPS RESEARCH INSTITUTE (US) 2023-06-08 — — WO disclosed
CN-111233869-B Novel compound for preparing Rudexilvir key intermediate and preparation method thereof 杭州新博思生物医药有限公司 2022-09-16 — — CN disclosed
CN-111233869-A Novel compound for preparing Rudexilvir key intermediate and preparation method thereof 杭州新博思生物医药有限公司 2020-06-05 — — CN disclosed
Send feedback